MABN842 Sigma-AldrichAnti-PERK Antibody, clone 4F6.1
This Anti-PERK Antibody, clone 4F6.1 is validated for use in Western Blotting and Immunohistochemistry (Paraffin) for the detection of PERK.
More>> This Anti-PERK Antibody, clone 4F6.1 is validated for use in Western Blotting and Immunohistochemistry (Paraffin) for the detection of PERK. Less<<Recommended Products
Overview
| Replacement Information |
|---|
Key Spec Table
| Species Reactivity | Key Applications | Host | Format | Antibody Type |
|---|---|---|---|---|
| H | WB, IH(P) | M | Purified | Monoclonal Antibody |
| References |
|---|
| Product Information | |
|---|---|
| Format | Purified |
| Presentation | Purified mouse monoclonal IgG2bκ antibody in buffer containing 0.1 M Tris-Glycine (pH 7.4), 150 mM NaCl with 0.05% sodium azide. |
| Quality Segment | MQ100 |
| Physicochemical Information |
|---|
| Dimensions |
|---|
| Materials Information |
|---|
| Toxicological Information |
|---|
| Safety Information according to GHS |
|---|
| Safety Information |
|---|
| Storage and Shipping Information | |
|---|---|
| Storage Conditions | Stable for 1 year at 2-8°C from date of receipt. |
| Packaging Information | |
|---|---|
| Material Size | 100 μg |
| Transport Information |
|---|
| Supplemental Information |
|---|
| Specifications |
|---|
| Global Trade ITEM Number | |
|---|---|
| Catalogue Number | GTIN |
| MABN842 | 04055977181678 |
Documentation
Anti-PERK Antibody, clone 4F6.1 MSDS
| Title |
|---|
Anti-PERK Antibody, clone 4F6.1 Certificates of Analysis
| Title | Lot Number |
|---|---|
| Anti-PERK, clone 4F6.1 - 3291399 | 3291399 |
| Anti-PERK, clone 4F6.1 - 3907009 | 3907009 |
| Anti-PERK, clone 4F6.1 - 4142772 | 4142772 |
| Anti-PERK, clone 4F6.1 -Q2586373 | Q2586373 |
| Anti-PERK, clone 4F6.1 Monoclonal Antibody | 2990469 |
| Anti-PERK, clone 4F6.1 Monoclonal Antibody | 3068047 |
Technical Info
| Title |
|---|
| Characterization of Estrogen Receptor α Phosphorylation Sites in Breast Cancer Tissue Using the SNAP i.d® 2.0 System |
| White Paper: Further considerations of antibody validation and usage. |



